CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS RECEIVING VENETOCLAX-BASED REGIMENS IN BRAZIL: A REAL-WORLD STUDY

Introduction: The combination of venetoclax with hypomethylating agents (VEM-HM) is considered standard of care for unfit or elderly patients with acute myeloid leukemia (AML). There are several real world studies describing complications and outcome of patients treated with venetoclax-based regimen...

全面介紹

書目詳細資料

發表在:	Hematology, Transfusion and Cell Therapy
Main Authors:	A Costa, RLR Baptista, M Guaraná, MPQ Neto, AA Johann, VA Mauad, C Chiattone, E Fagundes, FB Duarte, E Nunes, M Dibai, M Nucci
格式:	Article
語言:	英语
出版:	Elsevier 2024-10-01
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S253113792400991X